The anti-carbamylated protein antibody response is of overall low avidity despite extensive isotype switching.

MLA

Delft, Myrthe A. M.van, et al. “The Anti-Carbamylated Protein Antibody Response Is of Overall Low Avidity despite Extensive Isotype Switching.” Rheumatology, vol. 57, no. 9, Sept. 2018, pp. 1583–91. EBSCOhost, https://doi.org/10.1093/rheumatology/key135.

APA

Delft, M. A. M. van, Verheul, M. K., Burgers, L. E., Rantapää-Dahlqvist, S., Mil, A. H. M. van der H., Huizinga, T. W. J., Toes, R. E. M., & Trouw, L. A. (2018). The anti-carbamylated protein antibody response is of overall low avidity despite extensive isotype switching. Rheumatology, 57(9), 1583–1591. https://doi.org/10.1093/rheumatology/key135

Chicago

Delft, Myrthe A M van, Marije K Verheul, Leonie E Burgers, Solbritt Rantapää-Dahlqvist, Annette H M van der Helm-van Mil, Tom W J Huizinga, René E M Toes, and Leendert A Trouw. 2018. “The Anti-Carbamylated Protein Antibody Response Is of Overall Low Avidity despite Extensive Isotype Switching.” Rheumatology 57 (9): 1583–91. doi:10.1093/rheumatology/key135.